偏瘫型偏头痛患者终生抑郁患病率研究
本研究在89例明确诊断的偏瘫型偏头痛(HM)患者与235例无头痛对照中开展横断面问卷研究,评估终生抑郁患病率及其与偏头痛特征的关系。结果显示HM患者终生抑郁风险显著升高(OR 3.73,95%CI 2.18-6.38),急性抗偏头痛药物使用与终生抑郁相关。结论认为抑郁是单基因HM表型的一部分。
要点
- HM患者终生抑郁风险约为对照的3.73倍
- 急性抗偏头痛药物使用与终生抑郁相关
- HM预防性治疗前应考虑共病抑郁
核心结论
- 抑郁是单基因偏瘫型偏头痛表型的一部分。
- 需进一步研究HM基因在共病抑郁中的病理生理作用。
- 临床启动HM预防性治疗时应考虑共病抑郁。
研究设计与样本
- 横断面、经验证问卷研究,纳入89例明确诊断的HM患者与235例无头痛对照。
- 评估终生抑郁患病率及其与偏头痛特征的关系。
主要发现
- HM患者终生抑郁的比值比为3.73(95%CI 2.18-6.38),高于对照。
- 急性抗偏头痛药物使用与终生抑郁相关。
关键数值与推荐
- HM患者终生抑郁OR 3.73,95%CI 2.18-6.38。
临床怎么用
- 对HM患者应关注共病抑郁,尤其在开始预防性治疗时。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the prevalence of depression and determinants associated with depression in a large population of hemiplegic migraine (HM) patients. METHODS: We conducted a cross-sectional, validated questionnaire study among 89 well-defined HM patients and 235 headache-free controls. The prevalence of lifetime depression and its relation to migraine characteristics was assessed. RESULTS: HM patients had increased odds for lifetime depression (odds ratio 3.73, 95% confidence interval 2.18-6.38) compared with controls. Use of acute antimigraine medication was associated with lifetime depression. CONCLUSIONS: Depression is part of the monogenic hemiplegic migraine phenotype. Further studies are needed to elucidate the pathophysiologic role of HM genes in comorbid depression. For now, clinicians should take comorbid depression into consideration when starting prophylactic treatment of HM.
引用
- Louter MA, Pelzer N, de Boer I, et al. Prevalence of lifetime depression in a large hemiplegic migraine cohort. Neurology. 2016. PMID: 27807184
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。